Doxazosin Tablet
Product Images NDC 55154-7996

4 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 55154-7996). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Doxazosin-structure.jpg (Doxazosin Structure)

Doxazosin-structure.jpg (Doxazosin Structure)
Chemical structure of Doxazosin, the active ingredient shown in the image as a molecular diagram with rings, nitrogen atoms, and functional groups including methoxy and sulfonic acid components.*
FDA Label Image

Table3.jpg (Table3)

Table3.jpg (Table3)
Data table and bar chart summarizing effectiveness data from placebo-controlled trials of doxazosin, including symptom scores and maximum flow rates. The table presents mean baseline and mean change values for symptom score and maximum flow rate across three studies comparing placebo and doxazosin doses. The adjacent bar chart visualizes maximum flow rate improvements and symptom score changes for placebo, 4 mg, and 8 mg doxazosin in Study 2.*
FDA Label Image

Figure1.jpg (Figure1)

Figure1.jpg (Figure1)
This image contains two line graphs showing clinical data for Doxazosin compared to placebo over a 14-week treatment period. The left graph displays mean change in total symptom score from baseline, with Doxazosin showing greater symptom reduction than placebo. The right graph shows mean increase in maximum urinary flow rate (mL/sec) from baseline, with Doxazosin demonstrating higher flow rate improvement than placebo. Both graphs include error bars and sample sizes (N=50 for Doxazosin, N=47 for placebo).*
FDA Label Image

2mg Bag Label (7e2e0788 60a4 F586 7ece 7b27d5068dc8 00)

2mg Bag Label (7e2e0788 60a4 F586 7ece 7b27d5068dc8 00)
Drug facts panel for Doxazosin Tablets, USP 2 mg, package of 10 tablets. Includes storage instructions, dosage note, warning about child resistance and institutional use, and pharmacist dispensing guidance. Also lists packaging and distribution information by Major Pharmaceuticals and Cardinal Health.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.